Cargando…
Treatment of Severe Swallowing Dysfunction in Systemic Sclerosis with IVIG: Role of Antimuscarinic Antibodies
Oropharyngeal and esophageal dysmotility can cause serious clinical complications such as aspiration pneumonia, cachexia, and sarcopenia, with a resulting increase in mortality and disability. The current standard of care for the treatment of SSc-associated swallowing dysfunction is mainly supportiv...
Autores principales: | Mendoza, Fabian A., DiMarino, Anthony, Cohen, Sidney, Adkins, Christopher, Abdelbaki, Shady, Rattan, Satish, Cao, Christopher, Denuna-Rivera, Susie, Jimenez, Sergio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699580/ https://www.ncbi.nlm.nih.gov/pubmed/36431141 http://dx.doi.org/10.3390/jcm11226665 |
Ejemplares similares
-
Sleep disorders and the prevalence of asymptomatic nocturnal acid and non-acid reflux
por: Herdman, Christine, et al.
Publicado: (2013) -
Survey of anal sphincter dysfunction using anal manometry in patients with fecal incontinence: a possible guide to therapy
por: Mandaliya, Rohan, et al.
Publicado: (2015) -
IVIG for refractory dysphagia in Antisynthetase syndrome: A truth hard to swallow
por: Alnoukari, Mais, et al.
Publicado: (2022) -
Use of Antimuscarinics in the Elderly
por: Patel, Bhavin, et al.
Publicado: (2009) -
Antimuscarinics for neurogenic overactive bladder in multiple
sclerosis: real-life data
por: Andretta, Elena, et al.
Publicado: (2022)